BCWORLD PHARM. Co. Ltd (200780) - Total Liabilities

Latest as of September 2025: ₩101.30 Billion KRW ≈ $68.65 Million USD

Based on the latest financial reports, BCWORLD PHARM. Co. Ltd (200780) has total liabilities worth ₩101.30 Billion KRW (≈ $68.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BCWORLD PHARM. Co. Ltd (200780) equity growth momentum to track the company's year-over-year net asset growth rate.

BCWORLD PHARM. Co. Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how BCWORLD PHARM. Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See BCWORLD PHARM. Co. Ltd (200780) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

BCWORLD PHARM. Co. Ltd Competitors by Total Liabilities

The table below lists competitors of BCWORLD PHARM. Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Kobexindo Tractors Tbk JK:KOBX	Indonesia	Rp2.98 Trillion
New York City REIT Inc NYSE:NYC	USA	$380.40 Million
Studio Mir Co. Ltd. KQ:408900	Korea	₩3.93 Billion
Digital Currency X Technology Inc. NASDAQ:DCX	USA	$709.20 Million
ISE Commerce Company Limited KQ:069920	Korea	₩51.31 Billion
Vunani Ltd JSE:VUN	South Africa	ZAC1.57 Billion
Reitmans Canada Ltd V:RET	Canada	CA$266.94 Million
Eagon Holdings Co.Ltd KQ:039020	Korea	₩375.64 Billion

Liability Composition Analysis (2015–2024)

This chart breaks down BCWORLD PHARM. Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BCWORLD PHARM. Co. Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.52	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.40	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.58	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BCWORLD PHARM. Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BCWORLD PHARM. Co. Ltd (2015–2024)

The table below shows the annual total liabilities of BCWORLD PHARM. Co. Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩99.65 Billion ≈ $67.53 Million	-2.75%
2023-12-31	₩102.47 Billion ≈ $69.44 Million	-1.00%
2022-12-31	₩103.50 Billion ≈ $70.14 Million	+5.72%
2021-12-31	₩97.90 Billion ≈ $66.35 Million	+7.27%
2020-12-31	₩91.27 Billion ≈ $61.85 Million	+20.83%
2019-12-31	₩75.53 Billion ≈ $51.19 Million	+5.42%
2018-12-31	₩71.65 Billion ≈ $48.56 Million	+93.06%
2017-12-31	₩37.11 Billion ≈ $25.15 Million	+64.62%
2016-12-31	₩22.54 Billion ≈ $15.28 Million	+88.58%
2015-12-31	₩11.96 Billion ≈ $8.10 Million	--

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General

Market Cap

$21.41 Million

₩31.59 Billion KRW

Market Cap Rank

#24831 Global

#1779 in Korea

Share Price

₩3090.00

Change (1 day)

+3.00%

52-Week Range

₩2960.00 - ₩5870.00

All Time High

₩30700.49